Hepatitis B virus reactivation with rituximab-containing regimen

被引：21

作者：

Tsutsumi, Yutaka ^{[1
]}

Yamamoto, Yoshiya ^{[2
]}

Shimono, Joji ^{[1
]}

Ohhigashi, Hiroyuki ^{[1
]}

Teshima, Takanori ^{[3
]}

机构：

[1] Hakodate Municipal Hosp, Dept Hematol, Hakodate 1-10-1,Minato Cho, Hakodate, Hokkaido 0418680, Japan

[2] Hakodate Municipal Hosp, Dept Gastroenterol, Hakodate, Hokkaido 0418680, Japan

[3] Hokkaido Univ, Grad Sch Med, Dept Hematol, JIS-01663 Sapporo, Hokkaido, Japan

来源：

WORLD JOURNAL OF HEPATOLOGY | 2013年 / 5卷 / 11期

关键词：

Rituximab; Hepatitis B virus; Reactivation; Chemotherapy; Lamivudine; Non-Hodgkin's lymphoma;

D O I：

10.4254/wjh.v5.i11.612

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Rituximab is recognized as a useful drug for the treatment of B-cell non-Hodgkin's lymphoma and its use has been extended to such diseases as idiopathic thrombocytopenic purpura, thrombotic thrombocytopenic purpura, chronic rheumatoid arthritis and AN-CA-associated vasculitides. One serious complication associated with its use is the reactivation of hepatitis B virus and the search for methods to prevent this occurrence has resulted in the rapid accumulation of knowledge. In this review, we discuss case analyses from our department and other groups and outline the current knowledge on the topic and the remaining issues. (C) 2013 Baishideng Publishing Group Co., Limited. All rights reserved.

引用

页码：612 / 620

页数：9

共 50 条

[41] Hepatitis B Virus Reactivation and Role of Antiviral Prophylaxis in Lymphoma Patients With Past Hepatitis B Virus Infection Who Are Receiving Chemoimmunotherapy [J].

Koo, Yu Xuan ;

Tan, Daniel S. W. ;

Tan, Iain B. ;

Tao, Miriam ;

Chow, Wan Cheng ;

Lim, Soon Thye .

CANCER, 2010, 116 (01) :115-121

[42] A case report of hepatitis B virus reactivation 19 months after cessation of chemotherapy with rituximab [J].

Guo, Xiangjuan ;

Ji, Tongtong ;

Xin, Shengliang ;

Xu, Jinghang ;

Yu, Yanyan .

FRONTIERS IN IMMUNOLOGY, 2022, 13

[43] Risk of hepatitis B virus (HBV) reactivation in non-Hodgkin lymphoma patients receiving rituximab-chemotherapy: A meta-analysis [J].

Dong, Hua-Jie ;

Ni, Ling-Na ;

Sheng, Gui-Feng ;

Song, Hong-Lei ;

Xu, Jian-Zhong ;

Ling, Yang .

JOURNAL OF CLINICAL VIROLOGY, 2013, 57 (03) :209-214

[44] Reactivation of hepatitis B virus during rituximab treatment of a patient with follicular lymphoma [J].

Shih-Hung Yang ;

Sung-Hsin Kuo .

Annals of Hematology, 2008, 87 :325-327

[45] No hepatitis B reactivation in a patient with refractory antisynthetase syndrome successfully treated with rituximab [J].

Andres, Mariano ;

Courtney, Philip .

JOINT BONE SPINE, 2011, 78 (06) :653-654

[46] Current trends in management of hepatitis B virus reactivation in the biologic therapy era [J].

Mastroianni, Claudio M. ;

Lichtner, Miriam ;

Citton, Rita ;

Del Borgo, Cosmo ;

Rago, Angela ;

Martini, Helene ;

Cimino, Giuseppe ;

Vullo, Vincenzo .

WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (34) :3881-3887

[47] The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy [J].

Chen, Xiao-Qin ;

Peng, Jie-Wen ;

Lin, Gui-Nan ;

Li, Mei ;

Xia, Zhong-Jun .

MEDICAL ONCOLOGY, 2012, 29 (02) :1237-1241

[48] Reactivation of precore mutant hepatitis B virus in chemotherapy-treated patients [J].

Dai, MS ;

Lu, JJ ;

Chen, YC ;

Perng, CL ;

Chao, TY .

CANCER, 2001, 92 (11) :2927-2932

[49] Hyperammonaemic encephalopathy associated with rituximab-containing chemotherapy [J].

Nott, L. ;

Price, T. J. ;

Pittman, K. ;

Patterson, K. ;

Young, R. ;

Fletcher, J. .

INTERNAL MEDICINE JOURNAL, 2008, 38 (10) :800-803

[50] Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients [J].

Sung-Nan Pei ;

Chien-Hung Chen ;

Chuan-Mo Lee ;

Ming-Chung Wang ;

Ming-Chun Ma ;

Tsung-Hui Hu ;

Ching-Yuan Kuo .

Annals of Hematology, 2010, 89 :255-262

← 1 2 3 4 5 →